Report Detail
Global LFA-based Cardiac Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4528576 |
- 13 April, 2023 |
- Global |
- 103 Pages |
- GIR (Global Info Research) |
- Other
Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
According to our (Global Info Research) latest study, the global LFA-based Cardiac market size was valued at USD 3699.5 million in 2022 and is forecast to a readjusted size of USD 6161.8 million by 2029 with a CAGR of 7.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.
This report is a detailed and comprehensive analysis for global LFA-based Cardiac market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global LFA-based Cardiac market size and forecasts, in consumption value ($ Million), 2018-2029
Global LFA-based Cardiac market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global LFA-based Cardiac market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global LFA-based Cardiac market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for LFA-based Cardiac
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global LFA-based Cardiac market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Siemens, Danaher and Bio-Rad Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
LFA-based Cardiac market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Troponin I
Troponin T
CK-MB
Myoglobin
Others
Market segment by Application
Laboratory Testing
Point-of-care Testing
Market segment by players, this report covers
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe LFA-based Cardiac product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of LFA-based Cardiac, with revenue, gross margin and global market share of LFA-based Cardiac from 2018 to 2023.
Chapter 3, the LFA-based Cardiac competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and LFA-based Cardiac market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of LFA-based Cardiac.
Chapter 13, to describe LFA-based Cardiac research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of LFA-based Cardiac
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of LFA-based Cardiac by Type
- 1.3.1 Overview: Global LFA-based Cardiac Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global LFA-based Cardiac Consumption Value Market Share by Type in 2022
- 1.3.3 Troponin I
- 1.3.4 Troponin T
- 1.3.5 CK-MB
- 1.3.6 Myoglobin
- 1.3.7 Others
- 1.4 Global LFA-based Cardiac Market by Application
- 1.4.1 Overview: Global LFA-based Cardiac Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Laboratory Testing
- 1.4.3 Point-of-care Testing
- 1.5 Global LFA-based Cardiac Market Size & Forecast
- 1.6 Global LFA-based Cardiac Market Size and Forecast by Region
- 1.6.1 Global LFA-based Cardiac Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global LFA-based Cardiac Market Size by Region, (2018-2029)
- 1.6.3 North America LFA-based Cardiac Market Size and Prospect (2018-2029)
- 1.6.4 Europe LFA-based Cardiac Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific LFA-based Cardiac Market Size and Prospect (2018-2029)
- 1.6.6 South America LFA-based Cardiac Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa LFA-based Cardiac Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche LFA-based Cardiac Product and Solutions
- 2.1.4 Roche LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Roche Recent Developments and Future Plans
- 2.2 Abbott
- 2.2.1 Abbott Details
- 2.2.2 Abbott Major Business
- 2.2.3 Abbott LFA-based Cardiac Product and Solutions
- 2.2.4 Abbott LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Abbott Recent Developments and Future Plans
- 2.3 Siemens
- 2.3.1 Siemens Details
- 2.3.2 Siemens Major Business
- 2.3.3 Siemens LFA-based Cardiac Product and Solutions
- 2.3.4 Siemens LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Siemens Recent Developments and Future Plans
- 2.4 Danaher
- 2.4.1 Danaher Details
- 2.4.2 Danaher Major Business
- 2.4.3 Danaher LFA-based Cardiac Product and Solutions
- 2.4.4 Danaher LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Danaher Recent Developments and Future Plans
- 2.5 Bio-Rad Laboratories
- 2.5.1 Bio-Rad Laboratories Details
- 2.5.2 Bio-Rad Laboratories Major Business
- 2.5.3 Bio-Rad Laboratories LFA-based Cardiac Product and Solutions
- 2.5.4 Bio-Rad Laboratories LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Bio-Rad Laboratories Recent Developments and Future Plans
- 2.6 BioMérieux
- 2.6.1 BioMérieux Details
- 2.6.2 BioMérieux Major Business
- 2.6.3 BioMérieux LFA-based Cardiac Product and Solutions
- 2.6.4 BioMérieux LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 BioMérieux Recent Developments and Future Plans
- 2.7 Thermo Fisher
- 2.7.1 Thermo Fisher Details
- 2.7.2 Thermo Fisher Major Business
- 2.7.3 Thermo Fisher LFA-based Cardiac Product and Solutions
- 2.7.4 Thermo Fisher LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Thermo Fisher Recent Developments and Future Plans
- 2.8 Ortho Clinical Diagnostics
- 2.8.1 Ortho Clinical Diagnostics Details
- 2.8.2 Ortho Clinical Diagnostics Major Business
- 2.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Product and Solutions
- 2.8.4 Ortho Clinical Diagnostics LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
- 2.9 LSI Medience Corporation
- 2.9.1 LSI Medience Corporation Details
- 2.9.2 LSI Medience Corporation Major Business
- 2.9.3 LSI Medience Corporation LFA-based Cardiac Product and Solutions
- 2.9.4 LSI Medience Corporation LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 LSI Medience Corporation Recent Developments and Future Plans
- 2.10 Randox laboratories
- 2.10.1 Randox laboratories Details
- 2.10.2 Randox laboratories Major Business
- 2.10.3 Randox laboratories LFA-based Cardiac Product and Solutions
- 2.10.4 Randox laboratories LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Randox laboratories Recent Developments and Future Plans
- 2.11 Wondfo Biotech
- 2.11.1 Wondfo Biotech Details
- 2.11.2 Wondfo Biotech Major Business
- 2.11.3 Wondfo Biotech LFA-based Cardiac Product and Solutions
- 2.11.4 Wondfo Biotech LFA-based Cardiac Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Wondfo Biotech Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global LFA-based Cardiac Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of LFA-based Cardiac by Company Revenue
- 3.2.2 Top 3 LFA-based Cardiac Players Market Share in 2022
- 3.2.3 Top 6 LFA-based Cardiac Players Market Share in 2022
- 3.3 LFA-based Cardiac Market: Overall Company Footprint Analysis
- 3.3.1 LFA-based Cardiac Market: Region Footprint
- 3.3.2 LFA-based Cardiac Market: Company Product Type Footprint
- 3.3.3 LFA-based Cardiac Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global LFA-based Cardiac Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global LFA-based Cardiac Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global LFA-based Cardiac Consumption Value Market Share by Application (2018-2023)
- 5.2 Global LFA-based Cardiac Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America LFA-based Cardiac Consumption Value by Type (2018-2029)
- 6.2 North America LFA-based Cardiac Consumption Value by Application (2018-2029)
- 6.3 North America LFA-based Cardiac Market Size by Country
- 6.3.1 North America LFA-based Cardiac Consumption Value by Country (2018-2029)
- 6.3.2 United States LFA-based Cardiac Market Size and Forecast (2018-2029)
- 6.3.3 Canada LFA-based Cardiac Market Size and Forecast (2018-2029)
- 6.3.4 Mexico LFA-based Cardiac Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe LFA-based Cardiac Consumption Value by Type (2018-2029)
- 7.2 Europe LFA-based Cardiac Consumption Value by Application (2018-2029)
- 7.3 Europe LFA-based Cardiac Market Size by Country
- 7.3.1 Europe LFA-based Cardiac Consumption Value by Country (2018-2029)
- 7.3.2 Germany LFA-based Cardiac Market Size and Forecast (2018-2029)
- 7.3.3 France LFA-based Cardiac Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom LFA-based Cardiac Market Size and Forecast (2018-2029)
- 7.3.5 Russia LFA-based Cardiac Market Size and Forecast (2018-2029)
- 7.3.6 Italy LFA-based Cardiac Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific LFA-based Cardiac Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific LFA-based Cardiac Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific LFA-based Cardiac Market Size by Region
- 8.3.1 Asia-Pacific LFA-based Cardiac Consumption Value by Region (2018-2029)
- 8.3.2 China LFA-based Cardiac Market Size and Forecast (2018-2029)
- 8.3.3 Japan LFA-based Cardiac Market Size and Forecast (2018-2029)
- 8.3.4 South Korea LFA-based Cardiac Market Size and Forecast (2018-2029)
- 8.3.5 India LFA-based Cardiac Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia LFA-based Cardiac Market Size and Forecast (2018-2029)
- 8.3.7 Australia LFA-based Cardiac Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America LFA-based Cardiac Consumption Value by Type (2018-2029)
- 9.2 South America LFA-based Cardiac Consumption Value by Application (2018-2029)
- 9.3 South America LFA-based Cardiac Market Size by Country
- 9.3.1 South America LFA-based Cardiac Consumption Value by Country (2018-2029)
- 9.3.2 Brazil LFA-based Cardiac Market Size and Forecast (2018-2029)
- 9.3.3 Argentina LFA-based Cardiac Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa LFA-based Cardiac Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa LFA-based Cardiac Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa LFA-based Cardiac Market Size by Country
- 10.3.1 Middle East & Africa LFA-based Cardiac Consumption Value by Country (2018-2029)
- 10.3.2 Turkey LFA-based Cardiac Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia LFA-based Cardiac Market Size and Forecast (2018-2029)
- 10.3.4 UAE LFA-based Cardiac Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 LFA-based Cardiac Market Drivers
- 11.2 LFA-based Cardiac Market Restraints
- 11.3 LFA-based Cardiac Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 LFA-based Cardiac Industry Chain
- 12.2 LFA-based Cardiac Upstream Analysis
- 12.3 LFA-based Cardiac Midstream Analysis
- 12.4 LFA-based Cardiac Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on LFA-based Cardiac. Industry analysis & Market Report on LFA-based Cardiac is a syndicated market report, published as Global LFA-based Cardiac Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of LFA-based Cardiac market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
